Find More Contacts for Denali Therapeutics
Ryan Watts
CEO
Executive Operations
2 phone numbers found
View contacts for Denali Therapeutics to access new leads and connect with decision-makers.
View All Contacts

Details

Edit Details Section
  • Stock Symbol  FRA:4DN
  • Company Type For Profit

Denali Therapeutics is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into

the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development.

Lists Featuring This Company

Edit Lists Featuring This Company Section
California Companies With More Than 10 Employees (Top 10K)
9,976 Number of Organizations • $1.2T Total Funding Amount • 73,440 Number of Investors
California Companies With Less Than $500M in Revenue (Top 10K)
9,784 Number of Organizations • $635.1B Total Funding Amount • 63,590 Number of Investors
Companies With Less Than $1B in Revenue (Top 10K)
9,862 Number of Organizations • $2T Total Funding Amount • 91,724 Number of Investors
Companies With Fewer Than 1000 Employees (Top 10K)
9,226 Number of Organizations • $1.2T Total Funding Amount • 92,294 Number of Investors

Frequently Asked Questions

Edit Frequently Asked Questions Section
Where is Denali Therapeutics's headquarters? Denali Therapeutics is located in San Francisco, California, United States.Who invested in Denali Therapeutics? Denali Therapeutics has 8 investors including Baillie Gifford and ARCH Venture Partners.How much funding has Denali Therapeutics raised to date? Denali Therapeutics has raised $347M.When was the last funding round for Denali Therapeutics? Denali Therapeutics closed its last funding round on Aug 25, 2016 from a Series B round.Who are Denali Therapeutics's competitors? Alternatives and possible competitors to Denali Therapeutics may include Fulcrum Therapeutics, Bluebird Bio, and Encoded Therapeutics.